CIK 0001501796 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Aura Biosciences, Inc.
Sign in to watch- Ticker
- AURA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 320271970
- Phone
- (617)500-8864
- Business address
- 80 GUEST STREET, BOSTON, MA, 02135
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market buy Director bought 199,601 shares at an average $7.19 ($1,434,987)
- 4 Open-market buy 10% owner bought 1,560,000 shares at $9.00 ($14,040,000)
- SC 13D/A Stake Beneficial Ownership Report
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Results of operations
- 4 Planned sale See Remarks sold 7,449 shares at $12.03 ($89,611)
- 4 Planned sale Chief Financial Officer sold 3,900 shares at $12.07 ($47,054)
- 424B5 Offering Prospectus
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 424B5 Offering Prospectus
- 8-K Event Regulation FD disclosure · Other events
- 4 Grant or award Chief Medical Officer acquired 135,000 shares (grant or award)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale Chief Financial Officer sold 3,385 shares at $6.82 ($23,091)
- 4 Open-market sale See Remarks sold 9,586 shares at $6.83 ($65,478)
- 3 Insider Initial Statement of Ownership
Page 12 of 20 · 383 filings